Welcome YoungGun. Tough question, but Ill take
Post# of 148179
(Total Views: 593)
Posted On: 12/17/2020 2:06:10 PM
Welcome YoungGun.
Tough question, but Ill take a swing. It all depends on whether we are able to deliver on an EUA for COVID, and BLA for HIV.
The HIV in US has faced a series of delays and mistakes with the submission, so that has tempered our expectations, but for me HIV in US and others has always been what I expected to set the floor of the share price.
COVID is a potential additional indication that could have short term and long term benefits to the share price, but for me is very difficult to predict to what extent.
Gun to my head, I think a year from now we will be somewhere around $20, but that is assuming that we have some success in COVID, and that Dr. Mahboob is able to get us on track with our HIV BLA's.
If we fail in COVID and are still having delays in a year for HIV, I suspect we will drift down to a dollar a share.
Tough question, but Ill take a swing. It all depends on whether we are able to deliver on an EUA for COVID, and BLA for HIV.
The HIV in US has faced a series of delays and mistakes with the submission, so that has tempered our expectations, but for me HIV in US and others has always been what I expected to set the floor of the share price.
COVID is a potential additional indication that could have short term and long term benefits to the share price, but for me is very difficult to predict to what extent.
Gun to my head, I think a year from now we will be somewhere around $20, but that is assuming that we have some success in COVID, and that Dr. Mahboob is able to get us on track with our HIV BLA's.
If we fail in COVID and are still having delays in a year for HIV, I suspect we will drift down to a dollar a share.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼